ConductScience.org, home

Paper23770577

Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer.

Ballester M and 7 others. Gynecol Oncol, 2013. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer. Papers, record 23770577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23770577

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer.
PubMed
Journal
Gynecol Oncol
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2013-08-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ballester MMarcos
2Canlorbe GGeoffroy
3Cortez AAnnie
4Gonin JJulie
5Laas EEnora
6Bendifallah SSofiane
7Graesslin OOlivier
8Daraï EEmile

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endometrial NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Receptors, ProgesteroneMajor topic
Blood Vessels
Female
Humans
Lymphatic Metastasis
Lymphatic Vessels
Neoplasm Grading
Neoplasm Invasiveness
Risk Factors

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42325994Risk Factors for the Prognosis of Endometrioid Endometrial Cancer: A Chinese Cohort Study.Obstet Gynecol Int2026https://conductscience.org/library/papers/42325994PubMed
39687493Prognostic and clinicopathological significance of survivin in gynecological cancer.Oncol Rev2024https://conductscience.org/library/papers/39687493PubMed
39682221Evaluation of Different Risk Factors for Metastatic Sentinel Lymph Nodes in Endometrial Cancer.Cancers (Basel)2024https://conductscience.org/library/papers/39682221PubMed
36908008The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer.Turk J Obstet Gynecol2023https://conductscience.org/library/papers/36908008PubMed
36077609Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.Cancers (Basel)2022https://conductscience.org/library/papers/36077609PubMed
35721388Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer.Clin Med Insights Oncol2022https://conductscience.org/library/papers/35721388PubMed
35453837Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.Diagnostics (Basel)2022https://conductscience.org/library/papers/35453837PubMed
34495379Developing a validated nomogram for predicting ovarian metastasis in endometrial cancer patients: a retrospective research.Arch Gynecol Obstet2022https://conductscience.org/library/papers/34495379PubMed
34422634Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma.Front Oncol2021https://conductscience.org/library/papers/34422634PubMed
34413681Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67.Cancer Manag Res2021https://conductscience.org/library/papers/34413681PubMed
34134781Immunotherapy in endometrial cancer: rationale, practice and perspectives.Biomark Res2021https://conductscience.org/library/papers/34134781PubMed
27163153Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.PLoS One2016https://conductscience.org/library/papers/27163153PubMed
25675149Just how accurate are the major risk stratification systems for early-stage endometrial cancer?Br J Cancer2015https://conductscience.org/library/papers/25675149PubMed
25406186Role of nuclear progesterone receptor isoforms in uterine pathophysiology.Hum Reprod Update2015https://conductscience.org/library/papers/25406186PubMed
24809776A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.Br J Cancer2014https://conductscience.org/library/papers/24809776PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23770577

GET https://conductscience.org/api/papers/v1/23770577/authors